D. Kieninger-Baum

发表

Serial examination of 20,248 newborns: Correlations between drug exposure and major malformations

A. Queisser-Luft, G. Stolz, K. Schlaefer, 1997 .

“Let the Algorithm Do the Work”: Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients

Martin Holder, Thomas Danne, O. Kordonouri, 2017, Diabetes technology & therapeutics.

Antibody persistence for 3 years following two doses of tetravalent measles–mumps–rubella–varicella vaccine in healthy children

M. Knuf, D. Kieninger-Baum, M. Douha, 2012, European Journal of Pediatrics.

Immunogenicity and safety of the quadrivalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine (MenACWY-TT) in 2–10-year-old children: results of an open, randomised, controlled study

M. Knuf, D. Kieninger-Baum, T. Fischbach, 2013, European Journal of Pediatrics.

Oil-in-water emulsion adjuvant with influenza vaccine in young children.

T. Vesikari, M. Knuf, P. Wutzler, 2011, The New England journal of medicine.

A dose-range study assessing immunogenicity and safety of one dose of a new candidate meningococcal serogroups A, C, W-135, Y tetanus toxoid conjugate (MenACWY-TT) vaccine administered in the second year of life and in young children.

J. Poolman, M. Knuf, D. Kieninger-Baum, 2010, Vaccine.

Serial examination of 20,248 newborn fetuses and infants: correlations between drug exposure and major malformations.

G. Stolz, K. Schlaefer, I. Eggers, 1996, American journal of medical genetics.

[Does maternal obesity increase the risk of fetal abnormalities? Analysis of 20,248 newborn infants of the Mainz Birth Register for detecting congenital abnormalities].

E. Merz, G. Stolz, K. Schlaefer, 1998, Ultraschall in der Medizin.

Safety and immunogenicity of an MF59-adjuvanted A/H1N1 pandemic influenza vaccine in children from three to seventeen years of age.

G. Leroux-Roels, M. Knuf, D. Kieninger-Baum, 2015, Vaccine.

Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6–35 Months of Age

G. Leroux-Roels, M. Knuf, D. Kieninger-Baum, 2014, The Pediatric infectious disease journal.

Manifestation of Diabetes Mellitus Type 1: A Questionnaire to Evaluate the Acceptance of Initial Intravenous Therapy

D. Kieninger-Baum, J. Pohlenz, Katrin Steul, 2014 .